Vireo Growth Inc.
corporate_fare Company Profile
Vireo Growth Inc. (OTC:VREOF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 33 items for VREOF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for VREOF spans 8-K, 10-Q, SCHEDULE 13D/A, S-4/A.
Recent high-impact activity:
- Vireo Amends Planet 13 Merger to Add Illinois IDFPR License Approval Condition
- Vireo Closes FLUENT Acquisition, Issues 6.15M Shares and Adds 33 Dispensaries
- Vireo 10-Q: Q3 Revenue $253.7M, Net Loss $24.0M, Debt Nearly Doubles to $293M
- Chicago Atlantic Group Reports 14.5% Vireo Stake After Fluent Credit Equitization
- Vireo Q3 Revenue Jumps 177% to $253.7M; Issues First Q4/Q1 Guidance
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 4,756 shares in VREOF as of the October 30, 2026 settlement, a 68.0% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 43.2% of VREOF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.